Evidence map›Paper›PMID 26305948›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2015

Structural basis of antizyme-mediated regulation of polyamine homeostasis.

Hsiang-Yi Wu, Shin-Fu Chen, Ju-Yi Hsieh, Fang Chou, Yu-Hsuan Wang, Wan-Ting Lin, Pei-Ying Lee, Yu-Jen Yu, Li-Ying Lin, Te-Sheng Lin and 5 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 75 citations in OpenAlex.

  1. Proteasomal surveillance of exposed cysteines.bioRxiv : the preprint server for biology · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Polyamine homeostasisbioRxiv : the preprint server for biology · 2025
    Article
  9. Review
  10. Article
  11. Protein degradation of antizyme depends on the N-terminal degrons.Protein science : a publication of the Protein Society · 2024
    Article
  12. Article
  13. Bachmann-Bupp syndrome and treatment.Developmental medicine and child neurology · 2024
    Review
  14. Review
  15. Article
  16. Biomolecules · 2023
    Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 1 country.

Hsiang-Yi WuInstitute of Biochemistry and Molecular Biology, College of Medicine, National Taiwan University, Taipei 100, Taiwan;
Shin-Fu ChenInstitute of Biochemistry and Molecular Biology, College of Medicine, National Taiwan University, Taipei 100, Taiwan;
Ju-Yi HsiehDepartment of Life Sciences and Institute of Genomics and Bioinformatics, National Chung Hsing University, Taichung 402, Taiwan;
Fang ChouInstitute of Biochemistry and Molecular Biology, College of Medicine, National Taiwan University, Taipei 100, Taiwan;
Yu-Hsuan WangDepartment of Life Sciences and Institute of Genomics and Bioinformatics, National Chung Hsing University, Taichung 402, Taiwan;
Wan-Ting LinInstitute of Biochemistry and Molecular Biology, College of Medicine, National Taiwan University, Taipei 100, Taiwan; Institute of Biochemistry, National Chung Hsing University, Taichung 402, Taiwan;
Pei-Ying LeeInstitute of Biochemistry and Molecular Biology, College of Medicine, National Taiwan University, Taipei 100, Taiwan; Institute of Biochemistry, National Chung Hsing University, Taichung 402, Taiwan;
Yu-Jen YuInstitute of Biochemistry and Molecular Biology, College of Medicine, National Taiwan University, Taipei 100, Taiwan;
Li-Ying LinInstitute of Biochemistry and Molecular Biology, College of Medicine, National Taiwan University, Taipei 100, Taiwan; Institute of Biochemistry, National Chung Hsing University, Taichung 402, Taiwan;
Te-Sheng LinInstitute of Biochemistry and Molecular Biology, College of Medicine, National Taiwan University, Taipei 100, Taiwan; Institute of Biochemistry, National Chung Hsing University, Taichung 402, Taiwan;
Chieh-Liang LinInstitute of Biochemistry and Molecular Biology, College of Medicine, National Taiwan University, Taipei 100, Taiwan;
Guang-Yaw LiuInstitute of Microbiology and Immunology, Chung Shan Medical University, Taichung 402, Taiwan; Division of Allergy, Immunology, and Rheumatology, Chung Shan Medical University Hospital, Taichung 402, Taiwan;
Shiou-Ru TzengInstitute of Biochemistry and Molecular Biology, College of Medicine, National Taiwan University, Taipei 100, Taiwan; nlchan@ntu.edu.tw srtzeng@ntu.edu.tw hchung@dragon.nchu.edu.tw.
Hui-Chih HungDepartment of Life Sciences and Institute of Genomics and Bioinformatics, National Chung Hsing University, Taichung 402, Taiwan; Agricultural Biotechnology Center, National Chung Hsing University, Taichung 402, Taiwan nlchan@ntu.edu.tw srtzeng@ntu.edu.tw hchung@dragon.nchu.edu.tw.
Nei-Li ChanInstitute of Biochemistry and Molecular Biology, College of Medicine, National Taiwan University, Taipei 100, Taiwan; Institute of Biochemistry, National Chung Hsing University, Taichung 402, Taiwan; nlchan@ntu.edu.tw srtzeng@ntu.edu.tw hchung@dragon.nchu.edu.tw.
National Taiwan University · TWNational Chung Hsing University · TWChung Shan Medical University · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Polyamines are organic polycations essential for cell growth and differentiation; their aberrant accumulation is often associated with diseases, including many types of cancer. To maintain polyamine homeostasis, the catalytic activity and protein abundance of ornithine decarboxylase (ODC), the committed enzyme for polyamine biosynthesis, are reciprocally controlled by the regulatory proteins antizyme isoform 1 (Az1) and antizyme inhibitor (AzIN). Az1 suppresses polyamine production by inhibiting the assembly of the functional ODC homodimer and, most uniquely, by targeting ODC for ubiquitin-independent proteolytic destruction by the 26S proteasome. In contrast, AzIN positively regulates polyamine levels by competing with ODC for Az1 binding. The structural basis of the Az1-mediated regulation of polyamine homeostasis has remained elusive. Here we report crystal structures of human Az1 complexed with either ODC or AzIN. Structural analysis revealed that Az1 sterically blocks ODC homodimerization. Moreover, Az1 binding triggers ODC degradation by inducing the exposure of a cryptic proteasome-interacting surface of ODC, which illustrates how a substrate protein may be primed upon association with Az1 for ubiquitin-independent proteasome recognition. Dynamic and functional analyses further indicated that the Az1-induced binding and degradation of ODC by proteasome can be decoupled, with the intrinsically disordered C-terminal tail fragment of ODC being required only for degradation but not binding. Finally, the AzIN-Az1 structure suggests how AzIN may effectively compete with ODC for Az1 to restore polyamine production. Taken together, our findings offer structural insights into the Az-mediated regulation of polyamine homeostasis and proteasomal degradation.

Indexed as

HomeostasisAmino Acid SequenceBiocatalysisCarrier ProteinsCrystallography, X-RayEnzyme InhibitorsHumansKineticsModels, MolecularMolecular Sequence DataOrnithine DecarboxylasePolyaminesProteasome Endopeptidase ComplexProtein BindingProtein ConformationProtein MultimerizationATP dependent 26S proteaseAZIN1 protein, humanCarrier ProteinsEnzyme InhibitorsOrnithine Decarboxylaseornithine decarboxylase antizymePolyaminesProteasome Endopeptidase ComplexProteinsantizymeantizyme inhibitorornithine decarboxylasepolyamine homeostasisubiquitin-independent proteolysis

Identifiers

PMID26305948
PMCPMC4568681
OpenAlexW2110297253

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.